The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Truex Paul F since 2010.
This trader's CIK number is 1120362.
At the time of last reporting, Truex Paul F was the Director of Milestone Pharmaceuticals Inc.. (stock ticker symbol MIST).
Also see all insider trading activities at Milestone Pharmaceuticals Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | MIST | 5,000 | $28,000 | 0 | $0 | 76,780 | $131,677 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | TSRX | 2,000 | $13,600 | 0 | $0 | 0 | $0 |
| 2010 | TSRX | 1,000 | $3,500 | 0 | $0 | 7,364 | $9,499 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ANTH | 5,000 | $6,700 | 0 | $0 | 0 | $0 |
| 2016 | ANTH | 0 | $0 | 0 | $0 | 5,008 | $10,416 |
| 2014 | ANTH | 0 | $0 | 0 | $0 | 2,000 | $4,160 |
| 2012 | ANTH | 20,000 | $15,200 | 30,000 | $218,850 | 20,000 | $5,200 |
| 2011 | ANTH | 0 | $0 | 119,980 | $842,289 | 80,000 | $20,800 |
| 2010 | ANTH | 1,000 | $7,140 | 0 | $0 | 23,364 | $3,270 |
1. Milestone Pharmaceuticals Inc. (MIST)
2. Trius Therapeutics Inc (TSRX)
3. Anthera Pharmaceuticals Inc (ANTH)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-05-31 | MIST | Buy | 5,000 | 5.60 | 28,000 |
| 2022-05-31 | MIST | Option Ex | 76,780 | 1.72 | 131,677 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-08-29 | TSRX | Buy | 2,000 | 6.80 | 13,600 |
| 2010-11-23 | TSRX | Buy | 1,000 | 3.50 | 3,500 |
| 2010-11-23 | TSRX | Option Ex | 7,364 | 1.29 | 9,499 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-09-07 | ANTH | Buy | 5,000 | 1.34 | 6,700 |
| 2016-09-20 | ANTH | Option Ex | 5,008 | 2.08 | 10,416 |
| 2014-06-30 | ANTH | Option Ex | 2,000 | 2.08 | 4,160 |
| 2012-06-29 | ANTH | Buy | 20,000 | .76 | 15,200 |
| 2012-02-15 | ANTH | Sale | 15,000 | 7.84 | 117,600 |
| 2012-01-31 | ANTH | Option Ex | 20,000 | .26 | 5,200 |
| 2012-01-17 | ANTH | Sale | 15,000 | 6.75 | 101,250 |
| 2011-12-15 | ANTH | Sale | 15,000 | 6.34 | 95,070 |
| 2011-11-15 | ANTH | Sale | 30,000 | 6.96 | 208,710 |
| 2011-10-21 | ANTH | Sale | 23,235 | 6.25 | 145,218 |
| 2011-10-18 | ANTH | Sale | 6,745 | 6.25 | 42,156 |
| 2011-08-08 | ANTH | Option Ex | 50,000 | .26 | 13,000 |
| 2011-07-15 | ANTH | Sale | 15,000 | 7.95 | 119,250 |
| 2011-06-15 | ANTH | Sale | 15,000 | 8.30 | 124,545 |
| 2011-05-16 | ANTH | Sale | 15,000 | 7.16 | 107,340 |
| 2011-04-13 | ANTH | Option Ex | 30,000 | .26 | 7,800 |
| 2010-04-07 | ANTH | Option Ex | 23,364 | .14 | 3,270 |
| 2010-03-01 | ANTH | Buy | 1,000 | 7.14 | 7,140 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Truex Paul F (Director of Milestone Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.